文献速递类风湿关节炎

类风湿关节炎患者甲氨蝶呤治疗第一年疾病感知的变化

Changes in the illness perceptions of patients with rheumatoid arthritis over the first year of methotrexate therapy.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

基于英国多中心队列RAMS(N=1087),描述RA患者起始MTX治疗后一年内疾病感知的轨迹及其与结局的关联。潜类别增长模型识别出积极感知组(N=322)、消极感知组(N=534)和改善组(N=231)三个亚组;消极感知组随访期间残疾、疼痛和疲劳更差,基线残疾与其他PROs与分组相关。

要点

  • RA患者起始MTX第一年内疾病感知可分为积极、消极和改善三个轨迹亚组。
  • 消极疾病感知组随访期间残疾、疼痛和疲劳结局更差,且控制炎症后仍成立。
  • 基线残疾及其他PROs与疾病感知轨迹分组相关,疾病感知或为可干预靶点。

核心结论

  • 消极疾病感知与RA患者随访期间较差的患者报告结局相关。
  • 改善组表明RA患者的疾病感知在治疗第一年内可以发生变化。
  • 疾病感知是潜在治疗靶点,需通过随机试验评估干预效果。

研究设计与样本

  • 数据来自英国多中心队列研究RAMS,纳入首次起始MTX治疗的RA患者。
  • 在基线、6个月和12个月进行评估,分析人群N=1087。
  • 使用潜类别增长模型识别B-IPQ八个条目轨迹相似的亚组,并以多项逻辑回归和线性混合模型分析。

主要发现

  • 识别出三个亚组:积极疾病感知组(N=322)、消极疾病感知组(N=534)和改善组(N=231)。
  • 改善组在随访期间从消极疾病感知转为积极疾病感知。
  • 基线残疾与分组相关:积极 vs 消极 RRR 0.37(95% CI 0.25, 0.54);改善 vs 消极 RRR 0.60(95% CI 0.43, 0.83)。
  • 其他PROs(疼痛、疲劳、焦虑、抑郁)也与分组相关。
  • 控制炎症后,消极组随访期间残疾、疼痛和疲劳仍比其他组更差。

关键数值与推荐

  • B-IPQ用于评估疾病感知,炎症评分采用2组分DAS28计算。
  • 基线残疾与积极 vs 消极组的RRR为0.37(95% CI 0.25, 0.54),改善 vs 消极组为0.60(95% CI 0.43, 0.83)。

临床怎么用

  • 在RA患者起始MTX治疗时评估疾病感知,识别消极感知或可改善的患者。
  • 对消极疾病感知患者可考虑心理或教育干预,但需随机试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the illness perceptions of patients with RA over the first year of MTX treatment, and the association between illness perceptions and outcomes. METHODS: Data came from the Rheumatoid Arthritis Medication Study (RAMS), a UK multicentre cohort study of RA patients starting MTX for the first time. Patients were assessed at baseline, and at 6 and 12 months. Patients completed the Brief Illness Perception Questionnaire (B-IPQ) at each assessment, as well as other patient-reported outcomes (PROs). The inflammation score (2-component DAS28) was calculated. Subgroups of patients with similar trajectories across the eight (B-IPQ) items were identified using a latent class growth model. Predictors of group membership were identified using multinomial logistic regression. Associations between subgroups and PROs over follow-up were assessed using linear mixed models. RESULTS: Three subgroups were identified in the analysis population (N = 1087): Positive illness perceptions (N = 322), Negative illness perceptions (N = 534) and Improvers (N = 231) who switched from negative to positive illness perceptions over follow-up. Baseline disability was associated with group membership [Positive vs Negative: relative risk ratio (RRR) 0.37, 95% CI: 0.25, 0.54; Improvers vs Negative: RRR 0.60, 95% CI: 0.43, 0.83], as were other PROs (pain, fatigue, anxiety, depression). The Negative group had worse disability, pain and fatigue over follow-up compared with the other groups, controlling for inflammation. CONCLUSION: Negative illness perceptions are associated with poor PROs over time. The Improvers subgroup illustrated that illness perceptions can change in RA. Illness perceptions represent a potential therapeutic target that should be assessed using randomized trials.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Gwinnutt JM, Norton S, Hyrich KL, et al. Changes in the illness perceptions of patients with rheumatoid arthritis over the first year of methotrexate therapy. Rheumatology (Oxford). 2021. PMID: 33188696. doi:10.1093/rheumatology/keaa615

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。